2021
DOI: 10.1016/j.jclinepi.2020.09.036
|View full text |Cite
|
Sign up to set email alerts
|

PCORnet® 2020: current state, accomplishments, and future directions

Abstract: Objective To describe PCORnet, a clinical research network developed for patient-centered outcomes research on a national scale. Study Design and Setting Descriptive study of the current state and future directions for PCORnet. We conducted cross-sectional analyses of the health systems and patient populations of the 9 Clinical Research Networks and 2 Health Plan Research Networks that are part of PCORnet. Results Within the Clinical Research… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
101
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 123 publications
(101 citation statements)
references
References 18 publications
0
101
0
Order By: Relevance
“…Established in April 2020 with funding from the Patient-Centered Outcomes Research Institute, the HERO research program is one of the research activities of PCORnet®, the National Patient-Centered Clinical Research Network ( pcornet.org ). 16 At its launch, the HERO research program included a registry ( ClinicalTrials.gov Identifier NCT04342806), data from which this manuscript reports, and a clinical trial on prophylactic use of hydroxychloroquine ( ClinicalTrials.gov Identifier NCT04334148). The clinical trial activated 40 recruitment sites, which were the primary sources of registry recruitment as well.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Established in April 2020 with funding from the Patient-Centered Outcomes Research Institute, the HERO research program is one of the research activities of PCORnet®, the National Patient-Centered Clinical Research Network ( pcornet.org ). 16 At its launch, the HERO research program included a registry ( ClinicalTrials.gov Identifier NCT04342806), data from which this manuscript reports, and a clinical trial on prophylactic use of hydroxychloroquine ( ClinicalTrials.gov Identifier NCT04334148). The clinical trial activated 40 recruitment sites, which were the primary sources of registry recruitment as well.…”
Section: Methodsmentioning
confidence: 99%
“…Registry members had to be 18 years or older and able to read English. Within health systems participating in PCORnet, 16 recruitment was done via advertisements, institution-wide emails, provider recommendations, and newsletters. Additional approaches included articles in the media, social media advertisement, and professional society solicitations.…”
Section: Methodsmentioning
confidence: 99%
“…Routinely collected real world data (RWD) are a powerful asset for an evolving pandemic response [1,2].…”
Section: Introductionmentioning
confidence: 99%
“…
Background: Routinely collected real world data (RWD) have great utility in aiding the novel coronavirus disease (COVID-19) pandemic response [1,2]. Here we present the international Observational Health Data Sciences and Informatics (OHDSI) [3] Characterizing Health Associated Risks, and Your Baseline Disease In SARS-COV-2 (CHARYBDIS) framework for standardisation and analysis of COVID-19 RWD.Methods: We conducted a descriptive cohort study using a federated network of data partners in the United States, Europe (the Netherlands, Spain, the UK, Germany, France and Italy) and Asia (South Korea and China).
…”
mentioning
confidence: 99%
See 1 more Smart Citation